Global Ophthalmic Viscosurgical Devices (OVD) Market Size By Type (Cohesive OVD, Dispersive OVD), By Application (Hospital, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Ophthalmic Viscosurgical Devices (OVD) Market was valued at USD 1.9 billion in 2023 and is projected to reach USD 3.3 billion by 2031, expanding at a CAGR of 7.0% during the forecast period from 2023 to 2031. OVDs are critical in modern ophthalmic surgeries, particularly cataract procedures, where they maintain intraocular space, protect corneal endothelium, and facilitate lens implantation. The rising prevalence of cataract cases, increasing geriatric population, and advancements in surgical techniques are key drivers supporting the market’s growth. The market is further propelled by growing access to ophthalmic care in emerging regions and the integration of premium IOLs (Intraocular Lenses) that require precise surgical assistance.

Drivers:

1. Increasing Prevalence of Cataract and Glaucoma:

The rising global burden of cataract, especially in aging populations, is a significant factor driving demand for OVDs. Glaucoma treatments and retina surgeries also utilize OVDs, boosting their broader adoption in ophthalmology.

2. Advancements in Ophthalmic Surgical Procedures:

Minimally invasive surgical techniques and femtosecond laser-assisted cataract surgeries have enhanced the demand for high-performance OVDs that provide superior viscoelasticity and safety during procedures.

3. Expansion of Eye Care Facilities in Emerging Markets:

Improved healthcare infrastructure and increased investment in ophthalmology services in Asia-Pacific, Latin America, and the Middle East are opening up new opportunities for market players.

Restraints:

1. High Cost of Advanced OVDs:

Premium OVDs, particularly cohesive-dispersive types, can be cost-prohibitive for healthcare systems in low- and middle-income countries, potentially limiting widespread adoption.

2. Reimbursement Challenges in Developing Economies:

Lack of standardized reimbursement for ophthalmic devices in some regions affects the affordability of surgical interventions that utilize OVDs.

Opportunity:

1. Technological Innovations and Product Differentiation:

Manufacturers are focusing on developing dual-behavior OVDs and combination products that offer both dispersive and cohesive properties in one device, improving surgical outcomes and procedural efficiency.

2. Rising Demand for Premium IOLs:

The increasing popularity of multifocal and toric IOLs necessitates precision surgery, driving the demand for advanced OVDs that facilitate clear visualization and control during implantation.

Market by System Type Insights:

Based on system type, Cohesive OVDs dominated the market in 2023 due to their superior ability to maintain anterior chamber space during surgery. They are preferred in phacoemulsification procedures. However, the Dispersive OVDs segment is expected to witness notable growth, driven by their protective qualities for intraocular tissues, especially in complex or high-risk surgeries.

Market by End-use Insights:

In terms of end-use, the Hospitals segment accounted for the largest share in 2023, supported by a high volume of cataract and glaucoma surgeries performed in hospital settings. The Ophthalmic Clinics segment is anticipated to grow rapidly owing to the proliferation of specialized eye care centers and increasing patient preference for outpatient surgical procedures.

Market by Regional Insights:

Regionally, North America held the largest share of the global OVD market in 2023, attributed to advanced healthcare systems, favorable reimbursement policies, and the presence of key manufacturers. The Asia-Pacific region is forecasted to exhibit the fastest growth during the forecast period, driven by a growing aging population, increased cataract incidence, and healthcare infrastructure development in countries like India and China.

Competitive Scenario:

Key players in the Global Ophthalmic Viscosurgical Devices Market include Johnson & Johnson Vision, Alcon Inc., Carl Zeiss Meditec AG, Bausch + Lomb, Rayner Surgical Group, Bohus BioTech AB, and CIMA Technology Inc. These companies focus on product innovation, regulatory approvals, and strategic partnerships to enhance their market share. Recent developments include:

2024: Alcon launched a next-generation OVD with dual-cohesive properties, improving procedural visibility and chamber stability.

2023: Johnson & Johnson Vision announced its expansion into emerging Asian markets with a new line of ophthalmic surgical products.

2023: Bausch + Lomb entered a distribution agreement with local healthcare providers in Latin America to improve accessibility to cataract solutions.

Scope of Work – Global Ophthalmic Viscosurgical Devices Market

Report Metric Details

Market Size (2023) USD 1.9 billion

Projected Market Size (2031) USD 3.3 billion

CAGR (2023-2031) 7.0%

Market Segments By System Type (Cohesive, Dispersive), By End-use (Hospitals, Clinics), By Region

Growth Drivers Rise in cataract surgeries, agin